Dr. Lal PathLabs launches SOVAAKA - a next-generation wellness centre blending science, technology, and personalized care

Dr. Lal PathLabs Limited ("Dr. Lal PathLabs"), one of India's most trusted diagnostics brands, today announced the launch of Sovaaka, its new-age Diagnostic Experience Centre in Gurugram.

Built on the philosophy of "Science Behind Wellness," Sovaaka introduces a new standard in preventive and lifestyle healthcare. As an advanced wellness initiative from the house of Dr. Lal PathLabs, the centre brings together precision diagnostics, cutting-edge technology, and medical expertise to help individuals take proactive control of their health.

Sovaaka offers a deeply personalised diagnostics-led wellness experience that goes beyond routine health checks. Its doctor-designed programs - including Eterna (for women) and Vita (for men) - are customised to an individual's age, gender, and lifestyle. It brings together advanced diagnostics such as high-sensitivity blood panels, genetic testing, AI-supported imaging, and seamlessly integrated digital health records. With end-to-end clinical report evaluation and tailored nutrition guidance, Sovaaka delivers a truly comprehensive, understanding of one's health and wellness trajectory.

"Sovaaka marks a pivotal moment in the evolution of diagnostics - from disease detection to disease prediction," said (Hony) Brig. Dr. Arvind Lal, Executive Chairman, Dr. Lal PathLabs. "In a world where Non-Communicable Diseases (NCDs) or Lifestyle Diseases are affecting millions silently, science-led wellness and early screening play a transformative role. Testing today can truly save tomorrow."

Equipped with low-dose CT, 1.5T MRI, DEXA scanning, genetic analysis, and a wide menu of routine and advanced blood tests, the centre ensures fast turnaround, comprehensive insights, and a deeply personalised evaluation experience.

"With Sovaaka, we are reimagining how preventive healthcare is delivered," said Mr. Shankha Banerjee, CEO, Dr. Lal PathLabs. "By bringing diagnostics, advanced imaging, and lifestyle-based programmes under one roof, we are creating a destination for individuals committed to investing in their long-term health."

The launch comes at a time when India is witnessing rapid growth in the preventive health and wellness segment, driven by increasing incidence of Non-Communicable Diseases, rising awareness, evolving lifestyles, and greater emphasis on early detection. With Sovaaka, Dr. Lal PathLabs takes a significant step forward in strengthening preventive care by offering comprehensive, evidence-backed solutions that empower individuals to understand their health better and act early.

Shares of Dr. Lal Path Labs Ltd. was last trading in BSE at Rs. 1502.25 as compared to the previous close of Rs. 1472.95. The total number of shares traded during the day was 5260 in over 771 trades.

The stock hit an intraday high of Rs. 1508.00 and intraday low of 1462.05. The net turnover during the day was Rs. 7831827.00.

Source : Equity Bulls

Keywords

DrLalPathLabs INE600L01024 HealthcareServices Diagnostics Sovaaka